Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Janet, Fricker"'
Autor:
Janet Fricker
Publikováno v:
EMJ Dermatology. :2-11
Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries. Such data is complementary with RCT having high internal validity but low external validity, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d16e95bbe03c706918d827c4aef41af
https://doi.org/10.33590/emjdermatol/10313052
https://doi.org/10.33590/emjdermatol/10313052
Autor:
Janet Fricker
Publikováno v:
EMJ Gastroenterology. :2-11
Prof Ghosh presented data from the UNITI studies exploring ustekinumab in primary or secondary nonresponders to TNF agonists (UNITI-1) and conventional therapy failures (UNITI-2). The data demonstrate that ustekinumab shows higher efficacy in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b955da0bb7c040a3f7043652a4eae090
https://doi.org/10.33590/emjgastroenterol/10310509
https://doi.org/10.33590/emjgastroenterol/10310509
Autor:
Janet Fricker
Publikováno v:
EMJ Hematology. :2-12
Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding the use of different chemotherapy backbones consistently showed the benefits of obinutuzumab (G)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::330927d9b3557e0b84ef2c81b95ef919
https://doi.org/10.33590/emjhematol/10314634
https://doi.org/10.33590/emjhematol/10314634
Autor:
Janet Fricker
Publikováno v:
EMJ Dermatology. :2-6
This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis. FAE, first developed in 1959 and approved in 1994, are available in two forms: dimethyl fumarate (DMF) alone (e.g. Skilarence®; Almirall Ltd., U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10d7ff14d48fbfac772c82589397ce4e
https://doi.org/10.33590/emjdermatol/10310454
https://doi.org/10.33590/emjdermatol/10310454
Autor:
Janet Fricker
Publikováno v:
EMJ Respiratory. :38-46
With new patient-centric and scientific networks being created, Prof Chorostowska-Wynimko explored how these initiatives, such as the European Alpha-1 Research Collaboration (EARCO) and the European Reference Network-LUNG Alpha1 Antitrypsin Deficienc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::169a885ba0803679b2a14a50bda798b0
https://doi.org/10.33590/emjrespir/10314829
https://doi.org/10.33590/emjrespir/10314829
Autor:
Janet Fricker
Publikováno v:
EMJ Cardiology. :38-46
Prof Masana presented evidence that low-density lipoprotein (LDL) cholesterol is a causal factor for atherosclerosis and that cardiovascular disease (CVD)-relative risk (RR) is reduced proportionally to LDL reductions, regardless of the type of monot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623b40231a35604811c5398f84508b99
https://doi.org/10.33590/emjcardiol/10314733
https://doi.org/10.33590/emjcardiol/10314733
Autor:
Janet Fricker
Publikováno v:
EMJ Allergy & Immunology. :34-39
Allergen immunotherapy (AIT) in the form of subcutaneous or sublingual immunotherapy (SCIT/SLIT) is the only treatment for allergic rhinitis (AR) and/or allergic asthma with long-term efficacy. Dr Fox considered the benefits for using real-world (RW)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1873c2c17755fab1e148178862d754b3
https://doi.org/10.33590/emjallergyimmunol/10310432
https://doi.org/10.33590/emjallergyimmunol/10310432
Autor:
Janet Fricker
Publikováno v:
EMJ Hematology. :36-43
The meeting was arranged as a series of conversations between experts, following a question and answer format with two speakers in each presentation. In the first presentation, Dr Soverini and Prof Lion discussed the importance of the timing and dept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e86b8fee49c980b0d7606c0a6c07cf9a
https://doi.org/10.33590/emjhematol/10313377
https://doi.org/10.33590/emjhematol/10313377
Autor:
Janet Fricker
Publikováno v:
European Medical Journal. :60-68
With the recent growth in oral anticancer agents (OAA), pharmacists working in the community have recognised the urgent need to develop safe and effective systems to administer and manage these drugs. For community pharmacists, education regarding OA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::150c81219c716240d24b62d90855fdd0
https://doi.org/10.33590/emj/10310935
https://doi.org/10.33590/emj/10310935
Autor:
Janet Fricker
Publikováno v:
EMJ Gastroenterology. :32-39
The goal of this symposium was to highlight the importance of early diagnosis, assessing prognostic factors, and treating to target in inflammatory bowel disease (IBD). In the introduction, Prof Colombel outlined the treat to target (T2T) and tight c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05e703f8e84b0b806094bc0df2d88d94
https://doi.org/10.33590/emjgastroenterol/10311358
https://doi.org/10.33590/emjgastroenterol/10311358